January 19, 2023
1 min watch
Save
VIDEO: New topical gel features advantages over typical anesthetics
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Richard L. Lindstrom, MD, previews the advantages of a new topical anesthetic.
“It’s actually our first new topical anesthetic in over a decade, and it has some advantages,” he said. “It has a rapid onset of action and a longer duration of action than the typical tetracaine or proparacaine that we use today.”
Iheezo (chloroprocaine hydrochloride ophthalmic gel, Harrow) was FDA approved for ocular surface anesthesia in September 2022.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Lindstrom reports consulting for Harrow.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.